{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:16:24Z","timestamp":1793225784890,"version":"4.5.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007465","name":"UiT The Arctic University of Norway","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007465","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fecal microbiota transplantation (FMT) has become an important treatment method in recurrent <jats:italic>Clostridioides difficile<\/jats:italic> infections and is under investigation as a treatment for several other diseases. FMT\u2019s mechanism of action is assumed to be through alterations of the colon microbiota. FMT can be delivered by several methods, but few studies have directly compared how FMT is distributed in the colon by different methods. Specifically, the proximal distribution of FMT delivered by enema is unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In eight participants, we administered contrast fluid (CF) with viscosity similar to an FMT in a crossover study design. First, CF was administered by colonoscopy, followed by an abdominal X-ray to visualize the CF distribution. Next, after four to eight weeks, participants were given CF, but as an enema, followed by a positioning procedure. X-rays were obtained before (enema \u00f7) and after (enema +) the positioning procedure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Proportion of participants with CF in cecum were 100% after colonoscopy, 50% after enema\u2009+\u2009and 38% after enema \u00f7. In the transverse colon, proportions were 100% (colonoscopy), 88% (enema +) and 63% (enema \u00f7). There were no adverse events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Interpretation<\/jats:title>\n                <jats:p>This study shows proof of concept for the distribution of FMT to proximal colon when delivered by enema. A positioning procedure after the enema slightly improves the proximal distribution. However, colonoscopy is the only method that ensures delivery to the cecum. Studies are needed to see if FMT colon distribution correlates with treatment effectiveness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The study was retrospectively registered at ClinicalTrials.gov (NCT05121285) (16\/11\/2021).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-023-02979-x","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T13:01:53Z","timestamp":1698066113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Colonic distribution of FMT by different enema procedures compared to colonoscopy \u2013 proof of concept study using contrast fluid"],"prefix":"10.1186","volume":"23","author":[{"given":"Linn Kallbekken","family":"Skjevling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege Marie","family":"Hanssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Christian","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus","family":"Goll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik Emil","family":"Juul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Arlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Holger","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"issue":"1","key":"2979_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(17)30338-2","volume":"3","author":"PH Johnsen","year":"2018","unstructured":"Johnsen PH, Hilpusch F, Cavanagh JP, Leikanger IS, Kolstad C, Valle PC, et al. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol. 2018;3(1):17\u201324.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"2979_CR2","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s13054-019-2604-5","volume":"23","author":"M Dai","year":"2019","unstructured":"Dai M, Liu Y, Chen W, Buch H, Shan Y, Chang L, et al. Rescue fecal microbiota transplantation for antibiotic-associated diarrhea in critically ill patients. Crit Care. 2019;23(1):324.","journal-title":"Crit Care"},{"issue":"8","key":"2979_CR3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/MCG.0000000000000046","volume":"48","author":"G Cammarota","year":"2014","unstructured":"Cammarota G, Ianiro G, Gasbarrini A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol. 2014;48(8):693\u2013702.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"2979_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12876-020-01285-0","volume":"20","author":"T Zhang","year":"2020","unstructured":"Zhang T, Long C, Cui B, Buch H, Wen Q, Li Q, et al. Colonic transendoscopic tube-delivered enteral therapy (with video): a prospective study. BMC Gastroenterol. 2020;20(1):135.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"2979_CR5","doi-asserted-by":"publisher","first-page":"E610","DOI":"10.1055\/s-0042-105205","volume":"4","author":"Z Peng","year":"2016","unstructured":"Peng Z, Xiang J, He Z, Zhang T, Xu L, Cui B, et al. Colonic transendoscopic enteral tubing: a novel way of transplanting fecal microbiota. Endosc Int Open. 2016;4(6):E610\u20133.","journal-title":"Endosc Int Open"},{"issue":"12","key":"2979_CR6","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1136\/gutjnl-2019-319548","volume":"68","author":"G Cammarota","year":"2019","unstructured":"Cammarota G, Ianiro G, Kelly CR, Mullish BH, Allegretti JR, Kassam Z, et al. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut. 2019;68(12):2111\u201321.","journal-title":"Gut"},{"key":"2979_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fcimb.2019.00002","volume":"9","author":"BC Wilson","year":"2019","unstructured":"Wilson BC, Vatanen T, Cutfield WS, O\u2019Sullivan JM. The Super-Donor Phenomenon in Fecal Microbiota Transplantation. Front Cell Infect Microbiol. 2019;9:2.","journal-title":"Front Cell Infect Microbiol"},{"key":"2979_CR8","doi-asserted-by":"publisher","first-page":"100642","DOI":"10.1016\/j.eclinm.2020.100642","volume":"29\u201330","author":"SMD Baunwall","year":"2020","unstructured":"Baunwall SMD, Lee MM, Eriksen MK, Mullish BH, Marchesi JR, Dahlerup JF, et al. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an updated systematic review and meta-analysis. EClinicalMedicine. 2020;29\u201330:100642.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2979_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/apt.16148","volume":"53","author":"C Marcella","year":"2021","unstructured":"Marcella C, Cui B, Kelly CR, Ianiro G, Cammarota G, Zhang F. Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020. Aliment Pharmacol Ther. 2021;53(1):33\u201342.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2 Pt 1","key":"2979_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0016-5107(06)80113-6","volume":"43","author":"BP Saunders","year":"1996","unstructured":"Saunders BP, Fukumoto M, Halligan S, Jobling C, Moussa ME, Bartram CI, et al. Why is colonoscopy more difficult in women? Gastrointest Endosc. 1996;43(2 Pt 1):124\u20136.","journal-title":"Gastrointest Endosc"},{"issue":"8","key":"2979_CR11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1055\/s-0029-1214899","volume":"41","author":"MA Khashab","year":"2009","unstructured":"Khashab MA, Pickhardt PJ, Kim DH, Rex DK. Colorectal anatomy in adults at computed tomography colonography: normal distribution and the effect of age, sex, and body mass index. Endoscopy. 2009;41(8):674\u20138.","journal-title":"Endoscopy"},{"issue":"7","key":"2979_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2165\/00002512-200219070-00005","volume":"19","author":"D O\u2019Mahony","year":"2002","unstructured":"O\u2019Mahony D, O\u2019Leary P, Quigley EM. Aging and intestinal motility: a review of factors that affect intestinal motility in the aged. Drugs Aging. 2002;19(7):515\u201327.","journal-title":"Drugs Aging"},{"issue":"15","key":"2979_CR13","first-page":"4099","volume":"594","author":"J Nick","year":"2016","unstructured":"Nick J, Spencer PGD, Simon J, Brookes. Marcello Costa. Insights into the mechanisms underlying colonic motor patterns. Physiological Soc. 2016;594(15):4099\u2013116.","journal-title":"Physiological Soc"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-023-02979-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-023-02979-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-023-02979-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T06:17:27Z","timestamp":1700374647000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-023-02979-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2979"],"URL":"https:\/\/doi.org\/10.1186\/s12876-023-02979-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]},"assertion":[{"value":"17 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the regional committee of medical ethics in Northern Norway (Regional Etisk Komit\u00e9 (REK)-NORD:267433). All participants signed informed consent before trial inclusion. The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Results from this study will be presented at national and international conferences.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Dissemination"}},{"value":"Not commissioned: externally peer reviewed. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0 International License), which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly sited and the use is non-commercial. See: .","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Provenance and peer-review"}},{"value":"PHJ: North Norway Health trust - Personal fee as physician at dep. of internal medicine and researcher in a 50\/50% position. South Eastern Norway Health Trust - Personal fee as researcher in a 20% position Principal investigator in REFIT 2 trial, An investigator-initiated and \u2013run randomized trial investigating fecal microbiota transplantation by enema in patients with irritable bowel syndrome. PCV: Principal investigator in the study \u201cFecal microbiota transplantation in severe obesity\u201d, The study is a RCT addressing FMT by enema in patients with severe obesity, initiated and run by the investigator and co-investigator. LCKS: The Research Council of Norway - Personal fee as a Ph.d. research fellow. Coordinating Investigator in the comeback study - An investigator-initiated and \u2013run randomized trial investigating fecal microbiota transplantation by enema in patients with chronic fatigue syndrome\/myalgic encephalomyelitis. Study co-worker in \u00abthe obesity study\u201d - An investigator-initiated and \u2013run randomized trial investigating fecal microbiota transplantation by enema in patients with severe obesity. Member scientific committee in the REFIT-2 trial - An investigator-initiated and \u2013run randomized trial investigating fecal microbiota transplantation by enema in patients with irritable bowel syndrome. Member scientific committee in the C.O.L.O.N.I.Z.E trial - An investigator-initiated and \u2013run randomized trial investigating fecal microbiota transplantation by enema versus oral vancomycin for primary Clostridioides difficile infection. HMH: Health Fund of Regional Health North Norway - Personal fee as a Ph.d. research fellow. Co-prinsipal investigator in \u201cfecal microbiota transplantation in severe obesity\u201d - A randomized controlled trial investigating fecal microbiota transplantation in patients with severe obesity. Subinvestigator in \u201cfecal microbiota transplantation in CFS\/ME\u201d - An randomized controlled trial investigating fecal microbiota transplantation in patients with CFS\/ME. Member scientific committee in REFIT2 trial - An investigator-initiated and \u2013run randomized trial investigating fecal microbiota transplantation by enema in patients with irritable bowel syndrome. Member scientific committee in COLONIZE trial - An investigator-initiated and \u2013run randomized trial investigating fecal microbiota transplantation by enema versus oral vancomycin for primary Clostridioides difficile infection. FEJ: South Eastern Norway Health Trust - Personal fee as a Ph.d. research fellow. Principal investigator in REFIT 2 trial - An investigator-initiated and \u2013run randomized trial investigating fecal microbiota transplantation by enema in patients with irritable bowel syndrome. Co-Principal investigator in COLONIZE trial - An investigator-initiated and \u2013run randomized trial investigating fecal microbiota transplantation by enema versus oral vancomycin for primary Clostridioides difficile infection.\u00d8A: Non declared. RG: Non declared.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"363"}}